The Utility of Cannabidiol in the Treatment of Refractory Epilepsy

Clinical Pharmacology and Therapeutics

Volumn 101, Issue 2, 2017, Pages 182-184

  Reddy, D S ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIDIOL; ANTICONVULSIVE AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; MEDICAL CANNABIS;

ARTICLE; BRAIN FUNCTION; CLINICAL FEATURE; CLINICAL PHARMACOLOGY; CLINICAL PRACTICE; DRUG HALF LIFE; DRUG RESISTANT EPILEPSY; HUMAN; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRANSLATIONAL RESEARCH; VOLUME OF DISTRIBUTION; ANIMAL; CLINICAL TRIAL (TOPIC); EPILEPSY; HALF LIFE TIME; METABOLIC CLEARANCE RATE; METABOLISM; PILOT STUDY;

ANIMALS; ANTICONVULSANTS; CANNABIDIOL; CLINICAL TRIALS AS TOPIC; EPILEPSY; HALF-LIFE; HUMANS; MEDICAL MARIJUANA; METABOLIC CLEARANCE RATE; PILOT PROJECTS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 85009250340     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1002/cpt.441     Document Type: Article

References (7)

1. Friedman, D. & Devinsky, O. Cannabinoids in the treatment of epilepsy. N. Engl. J. Med. 373, 1048–1458 (2015).
2. Devinsky, O. et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia 55, 791–802 (2014).
3. Blair, R.E., Deshpande, L.S. & DeLorenzo, R.J. Cannabinoids: is there a potential treatment role in epilepsy? Expert Opin. Pharmacother. 16, 1911–1914 (2015).
4. Hofmann, M.E. & Frazier, C.J. Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention. Neurosci Lett. 411, 11–16 (2007).
5. Gloss, D. & Vickrey, B. Cannabinoids for epilepsy. Cochrane Database of Systematic Reviews. Issue 3: Art.#CD009270 (2014).
6. Reddy, D.S. & Golub, V. The pharmacological basis of cannabis therapy for epilepsy. J. Pharmacol. Exp. Ther. 357, 45–55 (2016).
7. Porter, B.E. & Jacobson, C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav. 29, 574–577 (2013).